Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

Journal article

Hemelaar J. et al, (2020), The Lancet HIV, 7, e772 - e781

Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.

Journal article

Donovan J. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71, 2002 - 2005

Is increasing pretreatment HIV drug resistance a real menace or minor detail?

Journal article

Inzaule SC. et al, (2020), The lancet. HIV, 7, e316 - e317

Management of intracranial tuberculous mass lesions: How long should we treat for?

Journal article

Marais S. et al, (2020), Wellcome Open Research, 4

Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies

Journal article

Rohlwink UK. et al, (2019), Wellcome Open Research, 4, 204 - 204

Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa

Journal article

Faria NR. et al, (2019), PLOS Pathogens, 15, e1007976 - e1007976

Tuberculous meningitis: new tools and new approaches required

Journal article

Seddon J. et al, (2019)

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens.

Journal article

Inzaule SC. et al, (2019), The Lancet. Infectious Diseases, 19, e246 - e252

Load More